TrialJMIR mHealth and uHealth2026

Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes.

Chorong Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.